Telomir Pharmaceuticals, Inc. - Common Stock, no par value (TELO)

CUSIP: 87975F104

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock, no par value
Shares outstanding
34,382,284
Total 13F shares
2,332,205
Share change
-474,330
Total reported value
$3,240,559
Price per share
$1.39
Number of holders
31
Value change
-$616,944
Number of buys
13
Number of sells
30

Quarterly Holders Quick Answers

What is CUSIP 87975F104?
CUSIP 87975F104 identifies TELO - Telomir Pharmaceuticals, Inc. - Common Stock, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Telomir Pharmaceuticals, Inc. - Common Stock, no par value (TELO) as of Q3 2025

As of 30 Sep 2025, Telomir Pharmaceuticals, Inc. - Common Stock, no par value (TELO) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,332,205 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, RAYMOND JAMES FINANCIAL INC, UBS Group AG, STATE STREET CORP, Bank of New York Mellon Corp, Suncoast Equity Management, and NORTHERN TRUST CORP. This page lists 31 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.